Endothelial cell therapy may transform future of endothelial disease management

Skip to content

USA

Japan

Programs & Therapies
- Endothelial Disease
- Pipeline
About Us
- Our Focus
- Leadership
News
Careers
Resources
Contact Us

Programs & Therapies
- Endothelial Disease
- Pipeline
About Us
- Our Focus
- Leadership
News
Careers
Resources
Contact Us

Continue to Article

Caution: New Drug – Limited by Federal (or United States) law to investigational use

Seattle
Aurion Corporate Mailing Address
117 E. Louisa Street, #561
Seattle, WA 98102
+1-206-210-0058

Cambridge
Aurion Biotech
101 Cambridgepark Drive, 3rd Floor
Cambridge, MA 02140
+1-857-639-4143

Tokyo
Aurion Biotech Japan, LLC
1-6-4 Hirakawacho, Chiyoda-ku,
Tokyo 102-0093, Japan
+81-3-6555-2218

Facebook-f Linkedin-in

Back to top

Privacy Policy

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.